559 related articles for article (PubMed ID: 17002633)
21. Comparison of the in vitro storage properties of Amicus apheresis platelets collected using single- and double-needle procedures from the same donors.
Wagner SJ; Seetharaman S; Kurtz J
Transfusion; 2012 Mar; 52(3):524-8. PubMed ID: 21880047
[TBL] [Abstract][Full Text] [Related]
22. Storage of aliquots of apheresis platelets for neonatal use in syringes with and without agitation.
Diab Y; Wong E; Criss VR; Moroff G; Wagner SJ; Luban NL
Transfusion; 2011 Dec; 51(12):2642-6. PubMed ID: 21745210
[TBL] [Abstract][Full Text] [Related]
23. In vivo viability of extended 4°C-stored autologous apheresis platelets.
Stolla M; Fitzpatrick L; Gettinger I; Bailey SL; Pellham E; Christoffel T; Slichter SJ
Transfusion; 2018 Oct; 58(10):2407-2413. PubMed ID: 30203458
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo quality of leukoreduced apheresis platelets stored in a new platelet additive solution.
Dumont LJ; Cancelas JA; Graminske S; Friedman KD; Vassallo RR; Whitley PH; Rugg N; Dumont DF; Herschel L; Siegal AH; Szczepiorkowski ZM; Fender L; Razatos A
Transfusion; 2013 May; 53(5):972-80. PubMed ID: 22882530
[TBL] [Abstract][Full Text] [Related]
25. The effect of gamma irradiation on the quality of apheresis platelets during storage for 7 days.
Tynngård N; Studer M; Lindahl TL; Trinks M; Berlin G
Transfusion; 2008 Aug; 48(8):1669-75. PubMed ID: 18482187
[TBL] [Abstract][Full Text] [Related]
26. In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST Collaborative.
Dumont LJ; AuBuchon JP; Gulliksson H; Slichter SJ; Elfath MD; Holme S; Murphy JR; Rose LE; Popovsky MA; Murphy S
Transfusion; 2006 Aug; 46(8):1300-5. PubMed ID: 16934063
[TBL] [Abstract][Full Text] [Related]
27. In vivo recovery of human platelets in severe combined immunodeficient mice as a measure of platelet damage.
Piper JT; Gelderman MP; Vostal JG
Transfusion; 2007 Aug; 47(8):1540-9. PubMed ID: 17655600
[TBL] [Abstract][Full Text] [Related]
28. Quality assessment of platelets stored in a modified platelet additive solution with trehalose at low temperature (10 °C) and in vivo effects on rabbit model of thrombocytopenia.
Wang X; Fan Y; Shi R; Li J; Zhao S
Platelets; 2015; 26(1):72-9. PubMed ID: 24499059
[TBL] [Abstract][Full Text] [Related]
29. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
[TBL] [Abstract][Full Text] [Related]
30. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.
Sandgren P; Callaert M; Shanwell A; Gulliksson H
Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluation of leukoreduced platelets stored for 7 days in CLX containers.
AuBuchon JP; Taylor H; Holme S; Nelson E
Transfusion; 2005 Aug; 45(8):1356-61. PubMed ID: 16078926
[TBL] [Abstract][Full Text] [Related]
32. Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial.
Heddle NM; Cook RJ; Blajchman MA; Barty RL; Sigouin CS; Boye DM; Nelson EJ; Kelton JG
Transfusion; 2005 Jun; 45(6):896-903. PubMed ID: 15934987
[TBL] [Abstract][Full Text] [Related]
33. Platelet concentrates prepared after a 20- to 24-hour hold of the whole blood at 22°C.
Slichter SJ; Corson J; Jones MK; Christoffel T; Pellham E; Bolgiano D
Transfusion; 2012 Sep; 52(9):2043-8. PubMed ID: 22320682
[TBL] [Abstract][Full Text] [Related]
34. In vitro testing of fresh and lyophilized reconstituted human and baboon platelets.
Valeri CR; Macgregor H; Barnard MR; Summaria L; Michelson AD; Ragno G
Transfusion; 2004 Oct; 44(10):1505-12. PubMed ID: 15383025
[TBL] [Abstract][Full Text] [Related]
35. Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial.
Pineda A; McCullough J; Benjamin RJ; Cable R; Strauss RG; Burgstaler E; Porter S; Lin L; Metzel P; Conlan MG;
Transfusion; 2006 Apr; 46(4):562-71. PubMed ID: 16584432
[TBL] [Abstract][Full Text] [Related]
36. Metabolomic analysis of platelets during storage: a comparison between apheresis- and buffy coat-derived platelet concentrates.
Paglia G; Sigurjónsson ÓE; Rolfsson Ó; Hansen MB; Brynjólfsson S; Gudmundsson S; Palsson BO
Transfusion; 2015 Feb; 55(2):301-13. PubMed ID: 25156572
[TBL] [Abstract][Full Text] [Related]
37. The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments.
Kleinman S; Dumont LJ; Tomasulo P; Bianco C; Katz L; Benjamin RJ; Gajic O; Brecher ME
Transfusion; 2009 May; 49(5):903-12. PubMed ID: 19170988
[TBL] [Abstract][Full Text] [Related]
38. The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates.
Zeiler T; Gritzka D; Karger R; Kretschmer V
Transfusion; 2004 Sep; 44(9):1300-5. PubMed ID: 15318852
[TBL] [Abstract][Full Text] [Related]
39. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions.
Lozano M; Galan A; Mazzara R; Corash L; Escolar G
Transfusion; 2007 Apr; 47(4):666-71. PubMed ID: 17381625
[TBL] [Abstract][Full Text] [Related]
40. A randomized controlled trial evaluating recovery and survival of 6% dimethyl sulfoxide-frozen autologous platelets in healthy volunteers.
Dumont LJ; Cancelas JA; Dumont DF; Siegel AH; Szczepiorkowski ZM; Rugg N; Pratt PG; Worsham DN; Hartman EL; Dunn SK; O'Leary M; Ransom JH; Michael RA; Macdonald VW
Transfusion; 2013 Jan; 53(1):128-37. PubMed ID: 22671278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
